KGK Synergize Inc.
London, Ontario, N6A 5R8, Canada
NCT Number: NCT02176889
The purpose of this study is to determine whether Lactospore is safe in healthy adults.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
London, Ontario, N6A 5R8, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bacillus coagulans MTCC 5856
Time frame: Over 30 days
CBC, electrolytes (Na, K, Cl), glucose, creatinine, AST, ALT, GGT, and bilirubin levels
Time frame: Over 30 days
Blood pressure, Heart Rate, Weight, BMI
Time frame: Over 30 days
KGK Science Inc.
Industry
A Double-blind, Placebo-controlled, Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals
Acronym: 14PSHS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details